general Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth admin 2025 年 10 月 30 日 No Comments Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth
Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth
Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth